Slide 1: First Quarter 2023 Earnings
First Quarter 2023 Earnings M a y 9 , 2 0 2 3
Slide 2: Forward-looking statements
These presentations contain forward-looking statements within the meaning of federal securities laws, including, among others, statements about our expectations, plans, strategies or prospects. We generally use the words “may,” “will,” “expect,” “believe,” “anticipate,” “plan,” “estimate,” “project,
Slide 3: First Quarter 2023 Financial Highlights
Consolidated Revenue $565 million First Quarter 2023 Financial Highlights(1) (1) Non-GAAP measures shown have been adjusted for certain items that are fully described in the Appendix. Please visit the Investor Relations section of the Company’s website at www.masimo.com to access additional informat
Slide 4: First Quarter 2023 Results | Non-GAAP
(In millions; except EPS) Actual Prior Year vs. Prior Revenue $565 $304 86% Healthcare 347 304 14% Non-Healthcare 218 N/A N/A Gross Profit $293 $205 42% Healthcare 215 205 5% Non-Healthcare 78 N/A N/A Gross Margin 51.8% 67.5% -1570 bps Healthcare 61.9% 67.5% -560 bps Non-Healthcare 35.6% N/A N/A Ope
Slide 5: Full Year 2023 Guidance as of May 9, 2023
Consolidated Revenue $2,415 to $2,460 million Full Year 2023 Guidance as of May 9, 2023(1) (1) Non-GAAP measures shown have been adjusted for certain items that are fully described in the Appendix. Please visit the Investor Relations section of the Company’s website at www.masimo.com to access addit
Slide 6: Full Year 2023 Guidance | Non-GAAP
Guidance vs. Prior Year (In millions; except EPS) Low High Prior Year Low High Revenue $2,415 $2,460 $2,036 19% 21% Healthcare 1,450 1,465 1,340 8% 9% Non-Healthcare 965 995 695 39% 43% Gross Profit $1,304 $1,330 $1,123 16% 18% Healthcare 920 931 870 6% 7% Non-Healthcare 384 399 252 52% 58% Gross Ma
Slide 7: Appendices: GAAP to Non-GAAP Reconciliations
Appendices GAAP to Non-GAAP Reconciliations
Slide 8: Income Statement
Consolidated Income Statement (1) Totals may not foot due to rounding. Annual reported amounts may vary from amounts previously reported due to rounding conventions. (2) 2023 Guidance provided on May 9, 2023. (Unaudited; in millions, except per share data) (1) Q1 2021 Q2 2021 Q3 2021 Q4 2021 FY 2021
Slide 9: Income Statement
Consolidated Income Statement (1) Totals may not foot due to rounding. Annual reported amounts may vary from amounts previously reported due to rounding conventions. (2) 2023 Guidance provided on May 9, 2023. (Unaudited; in millions, except per share data) (1) Q1 2021 Q2 2021 Q3 2021 Q4 2021 FY 2021
Slide 10: Revenue
Revenue (1) Totals may not foot due to rounding. Annual reported amounts may vary from amounts previously reported due to rounding conventions. (2) 2023 Guidance provided on May 9, 2023. (3) Constant currency adjustments are intended to reflect revenue at prior year foreign exchange rates for compar
Slide 11: Segment Reporting
Segment Reporting (1) Totals may not foot due to rounding. Annual reported amounts may vary from amounts previously reported due to rounding conventions. (2) 2023 Guidance provided on May 9, 2023. (Unaudited; in millions) (1) FY 2023 Guidance (2) Q1 2022 Q2 2022 Q3 2022 Q4 2022 FY 2022 Q1 2023 Low H